Key issues surrounding the health impacts of electronic nicotine delivery systems (ENDS) and other sources of nicotine

CA Cancer Journal for Clinicians

Volumn 67, Issue 6, 2017, Pages 449-471

  Drope, Jeffrey ^a   Cahn, Zachary ^a   Kennedy, Rosemary ^a   Liber, Alex C ^a   Stoklosa, Michal ^a   Henson, Rosemarie ^a   Douglas, Clifford E ^a   Drope, Jacqui ^a  

^a AMERICAN CANCER SOCIETY   (United States)

Author keywords

delivery systems; e cigarette; electronic nicotine; harm reduction; tobacco control

Indexed keywords

NICOTINE;

CARDIOVASCULAR DISEASE; ELECTRONIC NICOTINE DELIVERY SYSTEM; FOOD AND DRUG ADMINISTRATION; HARM REDUCTION; HIGH TEMPERATURE; HUMAN; JUVENILE; NICOTINE REPLACEMENT THERAPY; POPULATION RISK; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SMOKELESS TOBACCO; SMOKING CESSATION; SNUS; TOBACCO USE; TREND STUDY; ADVERSE DEVICE EFFECT; ELECTRONIC CIGARETTE; PROCEDURES; UNITED STATES; UTILIZATION;

ELECTRONIC CIGARETTES; HUMANS; NICOTINE; SMOKING CESSATION; UNITED STATES;

EID: 85030464538     PISSN: 00079235     EISSN: 15424863     Source Type: Journal    
DOI: 10.3322/caac.21413     Document Type: Review

References (132)

1. Tobacco Advisory Group of the Royal College of Physicians. Nicotine Without Smoke—Tobacco Harm Reduction. London, UK: Royal College of Physicians; 2016. rcplondon.ac.uk/projects/outputs/nicotine-without-smoke-tobacco-harm-reduction-0. Accessed August 28, 2017.
2. Goniewicz ML, Knysak J, Gawron M, et al. Levels of selected carcinogens and toxicants in vapour from electronic cigarettes. Tob Control. 2014;23:133-139.
3. Hecht SS, Carmella SG, Kotandeniya D, et al. Evaluation of toxicant and carcinogen metabolites in the urine of e-cigarette users versus cigarette smokers. Nicotine Tob Res. 2015;17:704-709.
4. Shahab L, Goniewicz ML, Blount BC, et al. Nicotine, carcinogen, and toxin exposure in long-term e-cigarette and nicotine replacement therapy users: a cross-sectional study. Ann Intern Med. 2017;166:390-400.
5. Arrazola RA, Singh T, Corey CG, et al. Tobacco use among middle and high school students—United States, 2011-2014. MMWR Morb Mortal Wkly Rep. 2015;64:381-385.
6. Ward BW, Schiller JS, Freeman G, Clarke TC. Early Release of Selected Estimates Based on Data From the January-June 2015 National Health Interview Survey. Hyattsville, MD: Division of Health Interview Statistics, National Center for Health Statistics, Centers for Disease Control and Prevention; 2015. cdc.gov/nchs/data/nhis/earlyrelease/earlyrelease201511.pdf. Accessed January 24, 2016.
7. Jamal A, Homa DM, O'Connor E, et al. Current cigarette smoking among adults—United States, 2005-2014. MMWR Morb Mortal Wkly Rep. 2015;64:1233-1240.
8. Fiore MC. Tobacco control in the Obama era—substantial progress, remaining challenges. N Engl J Med. 2016;375:1410-1412.
9. Orzechowski and Walker. The Tax Burden on Tobacco. Vol 49. Arlington, VA: Orzechowski and Walker; 2015.
10. Holford TR, Meza R, Warner KE, et al. Tobacco control and the reduction in smoking-related premature deaths in the United States, 1964-2012. JAMA. 2014;311:164-171.
11. Warner KE, Sexton DW, Gillespie BW, Levy DT, Chaloupka FJ. Impact of tobacco control on adult per capita cigarette consumption in the United States. Am J Public Health. 2014;104:83-89.
12. National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health. The Health Consequences of Smoking—50 Years of Progress: A Report of the Surgeon General. Atlanta, GA: Centers for Disease Control and Prevention; 2014. ncbi.nlm.nih.gov/books/NBK179276/. Accessed August 28, 2017.
13. Stuber J, Galea S, Link BG. Smoking and the emergence of a stigmatized social status. Soc Sci Med 1982. 2008;67:420-430.
14. Singh T, Arrazola RA, Corey CG, et al. Tobacco use among middle and high school students—United States, 2011-2015. MMWR Morb Mortal Wkly Rep. 2016;65:361-367.
15. Schoenborn CA, Gindi RM. Electronic Cigarette Use Among Adults: United States, 2014. Hyattsville, MD: National Center for Health Statistics; 2015. NCHS Data Brief No. 217.
16. Jamal A, Gentzke A, Hu SS, et al. Tobacco use among middle and high school students-United States, 2011-2016. MMWR Morb Mortal Wkly Rep. 2017;66:597-603.
17. Ambrose B. E-Cigarette Use Transitions: A Case Study from Waves 1 & 2 of the PATH Study. 2017. Presented at: Society for Research on Nicotine and Tobacco (SNRT) Pre-Conference Workshop: FDA's Population Health Standard: Balancing the Risks and Benefits in Regulatory Decision-Making; March 8, 2017; Florence, Italy. c.ymcdn.com/sites/www.srnt.org/resource/resmgr/conferences/2017_annual_meeting/FDA_PreCon_Slides/SRNT_2017_Pre-Conf_Workshop_.pdf. Accessed August 28, 2017.
18. Miech R, Patrick ME, O'Malley PM, Johnston LD. What are kids vaping? Results from a national survey of US adolescents. Tob Control. 2017;26:386-391.
19. Singh T, Kennedy S, Marynak K, Persoskie A, Melstrom P, King BA. Characteristics of electronic cigarette use among middle and high school students—United States, 2015. MMWR Morb Mortal Wkly Rep. 2016;65:1425-1429.
20. Cheah NP, Chong NW, Tan J, Morsed FA, Yee SK. Electronic nicotine delivery systems: regulatory and safety challenges: Singapore perspective. Tob Control. 2014;23:119-125.
21. Trehy ML, Ye W, Hadwiger ME, Moore TW, Allgire JF, Woodrff JT. Analysis of electronic cigarette cartridges, refill solutions, and smoke for nicotine and nicotine related impurities. J Liq Chromatogr Relat Technol. 2011;34:1442-1458.
22. Westenberger BJ. Evaluation of E-Cigarettes. St. Louis, MO: Division of Pharmaceutical Analysis, Center for Drug Evaluation and Research, Food and Drug Administration, Department of Health and Human Services; 2009.
23. Eriksen M, Mackay J, Schluger N, Gomeshtapeh F, Drope J. The Tobacco Atlas. 5th ed. Revised, Expanded and Updated. Atlanta, GA: American Cancer Society; 2015.
24. Wilson N, Peace J, Edwards R, Weerasekera D. Smokers commonly misperceive that nicotine is a major carcinogen: national survey data. Thorax. 2011;66:353-354.
25. Borrelli B, Novak SP. Nurses' knowledge about the risk of light cigarettes and other tobacco “harm reduction” strategies. Nicotine Tob Res. 2007;9:653-661.
26. American Cancer Society. Health Risks of Secondhand Smoke. Atlanta, GA: American Cancer Society; 2016. cancer.org/cancer/cancer-causes/tobacco-and-cancer/secondhand-smoke.html. Accessed August 28, 2017.
27. Meier BM, Shelley D. The fourth pillar of the Framework Convention on Tobacco Control: harm reduction and the international human right to health. Public Health Rep. 2006;121:494-500.
28. Tobacco Advisory Group of the Royal College of Physicians. Harm Reduction in Nicotine Addiction: Helping People Who Can't Quit. London, UK: Royal College of Physicians of London; 2007.
29. Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health. Nicotine addiction: past and present. In: How Tobacco Smoke Causes Disease: The Biology and Behavioral Basis for Smoking-Attributable Disease: A Report of the Surgeon General. Atlanta, GA: Centers for Disease Control and Prevention; 2010. ncbi.nlm.nih.gov/books/NBK53018/. Accessed August 28, 2017.
30. Fiore MC, Schroeder SA, Baker TB. Smoke, the chief killer—strategies for targeting combustible tobacco use. N Engl J Med. 2014;370:297-299.
31. National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health. Nicotine. In: The Health Consequences of Smoking—50 Years of Progress: A Report of the Surgeon General. Atlanta, GA: Centers for Disease Control and Prevention; 2014:109-138. surgeongeneral.gov/library/reports/50-years-of-progress/sgr50-chap-5.pdf. Accessed August 28, 2017.
32. Benowitz N. Nicotine toxicity. In: Ferrence J, Slade J, Room R, Pope M, eds. Nicotine and Public Health. Washington DC: American Public Health Association; 2000:65-76.
33. Ferrence R. Nicotine and Public Health. 1st ed. Washington, DC: American Public Health Association; 2000.
34. US Department of Health and Human Services, Office of the Surgeon General. E-Cigarette Use Among Youth and Young Adults: A Report of the Surgeon General. Rockville, MD: Office of the Surgeon General, Public Health Service, US Department of Health and Human Services; 2016. e-cigarettes.surgeongeneral.gov/documents/2016_SGR_Full_Report_non-508.pdf. Accessed August 28, 2017.
35. Hansson J, Galanti MR, Hergens MP, et al. Use of snus and acute myocardial infarction: pooled analysis of eight prospective observational studies. Eur J Epidemiol. 2012;27:771-779.
36. Kozlowski LT, Strasser AA, Giovino GA, Erickson PA, Terza JV. Applying the risk/use equilibrium: use medicinal nicotine now for harm reduction. Tob Control. 2001;10:201-203.
37. Hughes JR, Shiffman S, Callas P, Zhang J. A meta-analysis of the efficacy of over-the-counter nicotine replacement. Tob Control. 2003;12:21-27.
38. Dwyer M. Nicotine replacement therapies may not be effective in helping people quit smoking. Harvard School of Public Health News. January 9, 2012. hsph.harvard.edu/news/press-releases/nicotine-replacement-therapies/. Accessed August 28, 2017.
39. US Food and Drug Administration. Consumer Updates. FDA 101: Smoking Cessation Products. fda.gov/ForConsumers/ConsumerUpdates/ucm198176.htm. Accessed August 28, 2017.
40. Kotz D, Brown J, West R. “Real-world” effectiveness of smoking cessation treatments: a population study. Addiction. 2014;109:491-499.
41. The Clinical Practice Guideline Treating Tobacco Use and Dependence 2008 Update Panel, Liaisons, and Staff. A clinical practice guideline for treating tobacco use and dependence: 2008 update. A US Public Health Service Report. Am J Prev Med. 2008;35:158-176.
42. Stead LF, Perera R, Bullen C, et al. Nicotine replacement therapy for smoking cessation [serial online]. Cochrane Database Syst Rev. 2012;11:CD000146.
43. Lancaster T, Stead L, Silagy C, Sowden A. Effectiveness of interventions to help people stop smoking: findings from the Cochrane Library. BMJ. 2000;321:355-358.
44. Fiore MC, Jaen CR, Baker TB, et al. Treating Tobacco Use and Dependence: 2008 Update. Clinical Practice Guideline. Rockville, MD: US Department of Health and Human Services, Public Health Service; 2008.
45. Fiore MC, Baker TB. Clinical practice. Treating smokers in the health care setting. N Engl J Med. 2011;365:1222-1231.
46. Cepeda-Benito A, Reynoso JT, Erath S. Meta-analysis of the efficacy of nicotine replacement therapy for smoking cessation: differences between men and women. J Consult Clin Psychol. 2004;72:712-722.
47. Beard E, Bruguera C, McNeill A, Brown J, West R. Association of amount and duration of NRT use in smokers with cigarette consumption and motivation to stop smoking: a national survey of smokers in England. Addict Behav. 2015;40:33-38.
48. NIH State-of-the-Science Panel. National Institutes of Health State-of-the-Science conference statement: tobacco use: prevention, cessation, and control. Ann Intern Med. 2006;145:839-844.
49. National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health. The changing landscape of tobacco control—current status and future directions. In: The Health Consequences of Smoking—50 Years of Progress: A Report of the Surgeon General. Atlanta, GA: Centers for Disease Control and Prevention; 2014:647-699. surgeongeneral.gov/library/reports/50-years-of-progress/sgr50-chap-12.pdf. Accessed August 28, 2017.
50. Centers for Disease Control and Prevention, Office on Smoking and Health. Smoking and Tobacco Use. Fast Facts and Fact Sheets. Smoking and Tobacco Use. Atlanta, GA: Centers for Disease Control and Prevention; 2017. cdc.gov/tobacco/data_statistics/fact_sheets/fast_facts/. Accessed August 27, 2017.
51. Farsalinos KE, Spyrou A, Tsimopoulou K, Stefopoulos C, Romagna G, Voudris V. Nicotine absorption from electronic cigarette use: comparison between first and new-generation devices [serial online]. Sci Rep. 2014;4:4133.
52. Brandon TH, Goniewicz ML, Hanna NH, et al. Electronic nicotine delivery systems: a policy statement from the American Association for Cancer Research and the American Society of Clinical Oncology. J Clin Oncol. 2015;33:952-963.
53. iSmoke to Launch New E-Cigarette Line. Convenience Store News. May 2014. cspdailynews.com/category-news/tobacco/articles/ismoke-launch-new-e-cigarette-line. Accessed August 28, 2017.
54. Caputi TL. Industry watch: heat-not-burn tobacco products are about to reach their boiling point. Tob Control. 2017;26:609-610.
55. Wan W. Big Tobacco's new cigarette is sleek, smokeless—but is it any better for you? Washington Post. 2017. washingtonpost.com/national/health-science/big-tobaccos-new-cigarette-is-sleek-smokeless-but-is-it-actually-healthier/2017/08/11/60e9fe5a-763e-11e7-8839-ec48ec4cae25_story.html. Accessed August 24, 2017.
56. Chaudhuri S. Big Tobacco's Next Big Thing? Tobacco. Wall Street Journal. August 6, 2017. wsj.com/articles/big-tobaccos-next-big-thing-tobacco-1502017204. Accessed August 24, 2017.
57. Zhu SH, Sun JY, Bonnevie E, et al. Four hundred and sixty brands of e-cigarettes and counting: implications for product regulation. Tob Control. 2014;23(suppl 3):iii3-iii9.
58. World Health Organization (WHO) Framework Convention on Tobacco Control, Conference of the Parties to the WHO Framework Convention on Tobacco Control, 6th session. Electronic Nicotine Delivery Systems: Report by WHO. Geneva, Switzerland: World Health Organization; 2014. apps.who.int/gb/fctc/PDF/cop6/FCTC_COP6_10-en.pdf. Accessed August 28, 2017.
59. Herzog B. E-cigs revolutionizing the tobacco industry. Convenience Store News. September 2013. csnews.com/analyst-heat-not-burn-will-revolutionize-tobacco-industry. Accessed August 28, 2017.
60. Britton J, Arnott D, McNeill A, Hopkinson N; Tobacco Advisory Group of the Royal College of Physicians. Nicotine without smoke-putting electronic cigarettes in context [serial online]. BMJ. 2016;353:i1745.
61. Convenience Store Decisions (CSD) Staff. Cigarette sales decline as smokeless sales grow. Convenience Store Decisions. January 2017. cstoredecisions.com/2017/01/11/cigarette-sales-decline-smokeless-sales-grow/. Accessed August 28, 2017.
62. Blanding M, Drexler M. The e-cig quandary. Harvard Public Health Magazine. Spring 2015, 14-27.
63. Mulier T, Chambers S, Liefgreen D. Marlboro kicks some ash. Bloomberg Businessweek. 2016. bloomberg.com/news/articles/2016-03-24/marlboro-kicks-some-ash. Accessed August 28, 2017.
64. Hajek P, Etter JF, Benowitz N, Eissenberg T, McRobbie H. Electronic cigarettes: review of use, content, safety, effects on smokers and potential for harm and benefit. Addiction. 2014;109:1801-1810.
65. Flouris AD, Chorti MS, Poulianiti KP, et al. Acute impact of active and passive electronic cigarette smoking on serum cotinine and lung function. Inhal Toxicol. 2013;25:91-101.
66. Zhang Y, Sumner W, Chen DR. In vitro particle size distributions in electronic and conventional cigarette aerosols suggest comparable deposition patterns. Nicotine Tob Res. 2013;15:501-508.
67. Farsalinos KE, Polosa R. Safety evaluation and risk assessment of electronic cigarettes as tobacco cigarette substitutes: a systematic review. Ther Adv Drug Saf. 2014;5:67-86.
68. Nutt DJ, Phillips LD, Balfour D, et al. Estimating the harms of nicotine-containing products using the MCDA approach. Eur Addict Res. 2014;20:218-225.
69. McNeill A, Brose LS, Calder R, Hitchman SC, Hajek P, McRobbie H. E-Cigarettes: An Evidence Update. London, UK: Public Health England; 2015. gov.uk/government/publications/e-cigarettes-an-evidence-update. Accessed September 16, 2015.
70. E-cigarettes: Public Health England's evidence-based confusion [editorial]. Lancet. 2015;386:829.
71. Pisinger C, Dossing M. A systematic review of health effects of electronic cigarettes. Prev Med. 2014;69:248-260.
72. Callahan-Lyon P. Electronic cigarettes: human health effects. Tob Control. 2014;23(suppl 2):ii36-ii40.
73. Cheng T. Chemical evaluation of electronic cigarettes. Tob Control. 2014;23(suppl 2):ii11-ii17.
74. Burstyn I. Peering through the mist: systematic review of what the chemistry of contaminants in electronic cigarettes tells us about health risks [serial online]. BMC Public Health. 2014;14:18.
75. Farsalinos KE, Gillman G, Poulas K, Voudris V. Tobacco-specific nitrosamines in electronic cigarettes: comparison between liquid and aerosol levels. Int J Environ Res Public Health. 2015;12:9046-9053.
76. Saffari A, Daher N, Ruprecht A, et al. Particulate metals and organic compounds from electronic and tobacco-containing cigarettes: comparison of emission rates and secondhand exposure. Environ Sci Process Impacts. 2014;16:2259-2267.
77. Jensen RP, Luo W, Pankow JF, Strongin RM, Peyton DH. Hidden formaldehyde in e-cigarette aerosols. N Engl J Med. 2015;372:392-394.
78. Farsalinos KE, Voudris V, Poulas K. E-cigarettes generate high levels of aldehydes only in “dry puff” conditions. Addict Abingdon Engl. 2015;110:1352-1356.
79. Nitzkin JL, Farsalinos K, Siegel M. More on hidden formaldehyde in e-cigarette aerosols [letter]. N Engl J Med. 2015;372:1575.
80. Lerner CA, Sundar IK, Yao H, et al. Vapors produced by electronic cigarettes and e-juices with flavorings induce toxicity, oxidative stress, and inflammatory response in lung epithelial cells and in mouse lung [serial online]. PloS One. 2015;10:e0116732.
81. Meo SA, Al Asiri SA. Effects of electronic cigarette smoking on human health. Eur Rev Med Pharmacol Sci. 2014;18:3315-3319.
82. Durmowicz EL. The impact of electronic cigarettes on the paediatric population. Tob Control. 2014;23(suppl 2):ii41-ii46.
83. Kamboj A, Spiller HA, Casavant MJ, Chounthirath T, Smith GA. Pediatric exposure to e-cigarettes, nicotine, and tobacco products in the United States [serial online]. Pediatrics. 2016;137.; pii: e20160041.
84. West R, Hajek P, McNeill A, Brown J, Arnott D. Electronic cigarettes: what we know so far. Presentation to the UK All-Party Parliamentary Group on Pharmacy. June 10, 2014. discovery.ucl.ac.uk/1447624/. Accessed September 9, 2017.
85. Nelluri B, Murphy K, Mookadam F, Mookadam M. The current literature regarding the cardiovascular effects of electronic cigarettes. Future Cardiol. 2016;12:167-179.
86. Ioakeimidis N, Vlachopoulos C, Tousoulis D. Efficacy and safety of electronic cigarettes for smoking cessation: a critical approach. Hellenic J Cardiol. 2016;57:1-6.
87. Bhatnagar A. E-cigarettes and cardiovascular disease risk: evaluation of evidence, policy implications, and recommendations. Curr Cardiovasc Risk Rep. 2016;10:1-10.
88. Carnevale R, Sciarretta S, Violi F, et al. Acute impact of tobacco vs electronic cigarette smoking on oxidative stress and vascular function. Chest. 2016;150:606-612.
89. Vlachopoulos C, Ioakeimidis N, Abdelrasoul M, et al. Electronic cigarette smoking increases aortic stiffness and blood pressure in young smokers. J Am Coll Cardiol. 2016;67:2802-2803.
90. Loomis D, Guyton KZ, Grosse Y, et al. Carcinogenicity of drinking coffee, mate, and very hot beverages. Lancet Oncol. 2016;17:877-878.
91. Kozlowski LT, Warner KE. Adolescents and e-cigarettes: objects of concern may appear larger than they are. Drug Alcohol Depend. 2017;174:209-214.
92. Schneider S, Diehl K. Vaping as a catalyst for smoking? An initial model on the initiation of electronic cigarette use and the transition to tobacco smoking among adolescents. Nicotine Tob Res. 2016;18:647-653.
93. Pepper JK, Reiter PL, McRee AL, Cameron LD, Gilkey MB, Brewer NT. Adolescent males' awareness of and willingness to try electronic cigarettes. J Adolesc Health. 2013;52:144-150.
94. Wills TA, Knight R, Williams RJ, Pagano I, Sargent JD. Risk factors for exclusive e-cigarette use and dual e-cigarette use and tobacco use in adolescents. Pediatrics. 2015;135:e43–51.
95. Peters RJ, Meshack A, Lin MT, Hill M, Abughosh S. The social norms and beliefs of teenage male electronic cigarette use. J Ethn Subst Abuse. 2013;12:300-307.
96. Levy DT, Cummings KM, Villanti AC, et al. A framework for evaluating the public health impact of e-cigarettes and other vaporized nicotine products. Addiction. 2016;112:8-17.
97. Hernandez M, Pudney S. What You Don't See Can't Hurt You? Panel Data Analysis and the Dynamics of Unobservable Factors. ISER Working Paper Series. Colchester, UK: Institute for Social and Economic Research (ISER), University of Essex; 2011. econstor.eu/handle/10419/65953. Accessed September 17, 2015.
98. Miech R, Patrick ME, O'Malley PM, Johnston LD. E-cigarette use as a predictor of cigarette smoking: results from a 1-year follow-up of a national sample of 12th grade students [published online ahead of print February 6, 2017]. Tob Control. doi: 10.1136/tobaccocontrol-0000-0000.
99. Friedman AS. How does electronic cigarette access affect adolescent smoking? J Health Econ. 2015;44:300-308.
100. Pesko MF, Hughes JM, Faisal FS. The influence of electronic cigarette age purchasing restrictions on adolescent tobacco and marijuana use. Prev Med. 2016;87:207-212.
101. Abouk R, Adams S. Bans on electronic cigarette sales to minors and smoking among high school students. J Health Econ. 2017;54:17-24.
102. Malas M, van der Tempel J, Schwartz R, et al. Electronic cigarettes for smoking cessation: a systematic review. Nicotine Tob Res. 2016;18:1926-1936.
103. Hartmann-Boyce J, McRobbie H, Bullen C, Begh R, Stead LF, Hajek P. Electronic cigarettes for smoking cessation [serial online]. Cochrane Database Systematic Rev. 2016;9:CD010216.
104. Brown J, Beard E, Kotz D, Michie S, West R. Real-world effectiveness of e-cigarettes when used to aid smoking cessation: a cross-sectional population study. Addict. 2014;109:1531-1540.
105. Hajek P, McRobbie H, Bullen C. E-cigarettes and smoking cessation [serial online]. Lancet Respir Med. 2016;4:e23.
106. Hurt RD, Croghan GA, Wolter TD, et al. Does smoking reduction result in reduction of biomarkers associated with harm? A pilot study using a nicotine inhaler. Nicotine Tob Res. 2000;2:327-336.
107. Simmons MS, Connett JE, Nides MA, et al. Smoking reduction and the rate of decline in FEV(1): results from the Lung Health Study. Eur Respir J. 2005;25:1011-1017.
108. Pisinger C, Godtfredsen NS. Is there a health benefit of reduced tobacco consumption? A systematic review. Nicotine Tob Res. 2007;9:631-646.
109. QuickStats: cigarette smoking status among current adult e-cigarette users, by age group—National Health Interview Survey, United States, 2015 [serial online]. MMWR Morb Mortal Wkly Rep. 2016;65:1177.
110. O'Connell G, Graff DW, D'Ruiz CD. Reductions in biomarkers of exposure (BoE) to harmful or potentially harmful constituents (HPHCs) after partial or complete substitution of cigarettes with electronic cigarettes in adult smokers. Toxicol Mech Methods. 2016;26:443-454.
111. Klemperer EM, Hughes JR. Does the magnitude of reduction in cigarettes per day predict smoking cessation? A qualitative review. Nicotine Tob Res. 2016;18:88-92.
112. Goniewicz ML, Leigh NJ, Gawron M, et al. Dual use of electronic and tobacco cigarettes among adolescents: a cross-sectional study in Poland. Int J Public Health. 2016;61:189-197.
113. McCabe SE, West BT, Veliz P, Boyd CJ. E-cigarette use, cigarette smoking, dual use, and problem behaviors among U.S. adolescents: results from a national survey. J Adolesc Health. 2017;61:155-162.
114. McCabe SE, Veliz P, McCabe VV, Boyd CJ. Smoking behaviors and intentions among current e-cigarette users, cigarette smokers, and dual users: a national survey of U.S. high school seniors. Prev Med. 2017;99:228-235.
115. Centers for Disease Control and Prevention, Office on Smoking and Health. Smokeless Tobacco Use in the United States. Smoking and Tobacco Use: Betel Quid with Tobacco (Gutka). cdc.gov/tobacco/data_statistics/fact_sheets/smokeless/betel_quid/. Accessed August 28, 2017.
116. Piano MR, Benowitz NL, Fitzgerald GA, et al. Impact of smokeless tobacco products on cardiovascular disease: implications for policy, prevention, and treatment: a policy statement from the American Heart Association. Circulation. 2010;122:1520-1544.
117. Richter P, Spierto FW. Surveillance of smokeless tobacco nicotine, pH, moisture, and unprotonated nicotine content. Nicotine Tob Res. 2003;5:885-889.
118. International Agency for Research on Cancer (IARC) Working Group on the Evaluation of Carcinogenic Risk to Humans. Smokeless Tobacco and Some Tobacco-Specific N-Nitrosamines. Lyon, France; International Agency for Research on Cancer; 2007.
119. Stepanov I, Jensen J, Hatsukami D, Hecht SS. New and traditional smokeless tobacco: comparison of toxicant and carcinogen levels. Nicotine Tob Res. 2008;10:1773-1782.
120. World Health Organization. IARC Monographs Programme Finds Betel-Quid and Areca-Nut Chewing Carcinogenic to Humans. Geneva, Switzerland; World Health Organization; 2003. who.int/mediacentre/news/releases/2003/priarc/en/. Accessed August 28, 2017.
121. Foulds J, Ramstrom L, Burke M, Fagerstrom K. Effect of smokeless tobacco (snus) on smoking and public health in Sweden. Tob Control. 2003;12:349-359.
122. Tomar SL, Connolly GN, Wilkenfeld J, Henningfield JE. Declining smoking in Sweden: is Swedish Match getting the credit for Swedish tobacco control's efforts? Tob Control. 2003;12:368-371.
123. Blum A. Confronting America's Smoking Pandemic, Part 3: 1986-1999. Norwalk, CT: Cancer Network; 2016. cancernetwork.com/practice-policy/confronting-americas-smoking-pandemic-part-3-19861999. Accessed August 28, 2017.
124. US Food and Drug Administration. FDA Issues First Product Marketing Orders Through Premarket Tobacco Application Pathway [press release]. Silver Spring, MD: US Food and Drug Administration; 2015. fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm472026.htm. Accessed August 28, 2017.
125. Stepanov I, Jensen J, Hatsukami D, Hecht SS. Tobacco-specific nitrosamines in new tobacco products. Nicotine Tob Res. 2006;8:309-313.
126. Benowitz NL. Smokeless tobacco as a nicotine delivery device: harm or harm reduction? Clin Pharmacol Ther. 2011;90:491-493.
127. Scientific Committee on Emerging and Newly Identified Health Risks (SCENIHR). Health Effects of Smokeless Tobacco Products. Brussels, Belgium: Directorate General for Health and Food Safety, European Commission; 2008. ec.europa.eu/health/ph_risk/committees/04_scenihr/docs/scenihr_o_013.pdf. Accessed August 28, 2017.
128. Daniel Roth H, Roth AB, Liu X. Health risks of smoking compared to Swedish snus. Inhal Toxicol. 2005;17:741-748.
129. Levy DT, Mumford EA, Cummings KM, et al. The relative risks of a low-nitrosamine smokeless tobacco product compared with smoking cigarettes: estimates of a panel of experts. Cancer Epidemiol Biomark Prev. 2004;13:2035-2042.
130. Jorenby DE, Fiore MC, Smith SS, Baker TB. Treating cigarette smoking with smokeless tobacco: a flawed recommendation. Am J Med. 1998;104:499-500.
131. Kennedy RD, Awopegba A, De Leon E, Cohen JE. Global approaches to regulating electronic cigarettes. Tob Control. 2017;26:440-445.
132. Kozlowski LT, Edwards BQ. “Not safe” is not enough: smokers have a right to know more than there is no safe tobacco product. Tob Control. 2005;14(suppl 2):ii3-ii7.